Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats

被引:22
|
作者
Zhang, Zhengyu [1 ]
Tachikawa, Masanori [1 ]
Uchida, Yasuo [1 ]
Terasaki, Tetsuya [1 ]
机构
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi 9808578, Japan
关键词
blood-cerebrospinal fluid barrier; blood-arachnoid barrier; pharmacokinetics; organic anion transporters; oat1; oat3; leptomeninges; BLOOD-BRAIN-BARRIER; TARGETED ABSOLUTE PROTEOMICS; CANCER RESISTANCE PROTEIN; CHOROID-PLEXUS; P-GLYCOPROTEIN; FUNCTIONAL-CHARACTERIZATION; QUANTITATIVE ATLAS; JUNCTION PROTEINS; EXPRESSION LEVELS; SURROGATE;
D O I
10.1021/acs.molpharmaceut.7b00852
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Although arachnoid mater epithelial cells form the blood-arachnoid barrier (BAB), acting as a blood-CSF interface, it has been generally considered that the BAB is impermeable to water-soluble substances and plays a largely passive role. Here, we aimed to clarify the function of transporters at the BAB in regulating CSF clearance of water-soluble organic anion drugs based on quantitative targeted absolute proteomics (QTAP) and in vivo analyses. Protein expression levels of 61 molecules, including 19 ATP-binding-cassette (ABC) transporters and 32 solute-carrier (SLC) transporters, were measured in plasma membrane fraction of rat leptomeninges using QTAP. Thirty-three proteins were detected; others were under the quantification limits. Expression levels of multidrug resistance protein 1 (Mdr1a/P-gp/Abcb1a) and breast cancer resistance protein (Bcrp/Abcg2) were 16.6 and 3.27 fmol/mu g protein (51.9- and 9.82-fold greater than in choroid plexus, respectively). Among those organic anion transporters detected only at leptomeninges, not choroid plexus, organic anion transporter 1 (oat1/Slc22a6) showed the greatest expression (2.73 fmol/mu g protein). On the other hand, the protein expression level of oat3 at leptomeninges was 6.65 fmol/mu g protein, and the difference from choroid plexus was within two-fold. To investigate oat1's role, we injected para-aminohippuric acid (PAH) with or without oat1 inhibitors into cisterna magna (to minimize the contribution of choroid plexus function) of rats. A bulk flow marker, FITC-inulin, was not taken up from CSF up to 15 min, whereas uptake clearance of PAH was 26.5 mu L/min. PAH uptake was completely blocked by 3 mM cephalothin (inhibits both oat1 and oat3), while 17% of PAH uptake was inhibited by 0.2 mM cephalothin (selectively inhibits oat3). These results indicate that oat1 and oat3 at the BAB provide a distinct clearance pathway of organic anion drugs from CSF independently of choroid plexus.
引用
收藏
页码:911 / 922
页数:12
相关论文
共 50 条
  • [41] Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes:: Consequences for pravastatin pharmacokinetics
    Nishizato, Y
    Ieiri, I
    Suzuki, H
    Kimura, M
    Kawabata, K
    Hirota, T
    Takane, H
    Irie, S
    Kusuhara, H
    Urasaki, Y
    Urae, A
    Higuchi, S
    Otsubo, K
    Sugiyama, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) : 554 - 565
  • [42] Reduced Renal Clearance of Cefotaxime in Asians with a Low-Frequency Polymorphism of OAT3 (SLC22A8)
    Yee, Sook Wah
    Anh Nguyet Nguyen
    Brown, Chaline
    Savic, Radojka M.
    Zhang, Youcai
    Castro, Richard A.
    Cropp, Cheryl D.
    Choi, Ji Ha
    Singh, Diment
    Tahara, Harunobu
    Stocker, Sophie L.
    Huang, Yong
    Brett, Claire M.
    Giacomini, Kathleen M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (09) : 3451 - 3457
  • [43] Conformational Changes of the Multispecific Transporter Organic Anion Transporter 1 (OAT1/SLC22A6) Suggests a Molecular Mechanism for Initial Stages of Drug and Metabolite Transport
    Tsigelny, Igor F.
    Kovalskyy, Dmytro
    Kouznetsova, Valentina L.
    Balinskyi, Oleksii
    Sharikov, Yuriy
    Bhatnagar, Vibha
    Nigam, Sanjay K.
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2011, 61 (02) : 251 - 259
  • [44] Deletion of Multispecific Organic Anion Transporter Oat1/Slc22a6 Protects against Mercury-induced Kidney Injury
    Torres, Adriana M.
    Dnyanmote, Ankur V.
    Bush, Kevin T.
    Wu, Wei
    Nigam, Sanjay K.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (30) : 26391 - 26395
  • [45] Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin
    Yang, Jian
    Kalogerou, Maria
    Gallacher, John
    Sampson, Julian R.
    Shen, Ming Hong
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1479 - 1490
  • [46] Conformational Changes of the Multispecific Transporter Organic Anion Transporter 1 (OAT1/SLC22A6) Suggests a Molecular Mechanism for Initial Stages of Drug and Metabolite Transport
    Igor F. Tsigelny
    Dmytro Kovalskyy
    Valentina L. Kouznetsova
    Oleksii Balinskyi
    Yuriy Sharikov
    Vibha Bhatnagar
    Sanjay K. Nigam
    Cell Biochemistry and Biophysics, 2011, 61 : 251 - 259
  • [47] Interaction of H2-antagonists with human organic cation transporters hOCT1 (SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
    Bourdet, DL
    Pritchard, JB
    Thakker, DR
    DRUG METABOLISM REVIEWS, 2004, 36 : 262 - 262
  • [48] Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier
    Kikuchi, R
    Kusuhara, H
    Sugiyama, D
    Sugiyama, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (01): : 51 - 58
  • [49] Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3
    Gebauer, Lukas
    Jensen, Ole
    Rafehi, Muhammad
    Brockmoeller, Juergen
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (23) : 15990 - 16001
  • [50] Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
    Heise, Michael
    Lautem, Anja
    Knapstein, Johanna
    Schattenberg, Joern M.
    Hoppe-Lotichius, Maria
    Foltys, Daniel
    Weiler, Nina
    Zimmermann, Anca
    Schad, Arno
    Gruendemann, Dirk
    Otto, Gerd
    Galle, Peter R.
    Schuchmann, Marcus
    Zimmermann, Tim
    BMC CANCER, 2012, 12